0001127602-20-007086.txt : 20200224 0001127602-20-007086.hdr.sgml : 20200224 20200224085657 ACCESSION NUMBER: 0001127602-20-007086 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200220 FILED AS OF DATE: 20200224 DATE AS OF CHANGE: 20200224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ISHRAK OMAR CENTRAL INDEX KEY: 0001523102 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 20642174 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FISCAL YEAR END: 0424 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-02-20 0001613103 Medtronic plc MDT 0001523102 ISHRAK OMAR 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 1 1 Chairman & CEO Ordinary Shares 2020-02-20 4 P 0 8771 113.68 A 605190 D Ordinary Shares 18182 I 2019 GRAT Ordinary Shares 5900 I 2018 GRAT The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $113.65 to $113.70, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnote to this Form 4. This balance increased by 1,994 shares due to exempt transactions such as dividend reinvestment. /s/ Perry F. Sekus, attorney-in-fact 2020-02-24